Centiva Capital’s Bausch Health BHC Stock Holding History

Centiva Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200,000	Closed	-$1.67M	–	1494
2022 Q2	$1.67M	Buy	+200,000	New	+$2.8M	0.04%	408

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Centiva Capital's BHC Position: Q4 2025 in Review

Centiva Capital sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 77,753 shares — an estimated $502K sold.

Centiva Capital first reported a position in BHC in Q4 2019 and held it in 8 quarters. The position peaked at $951K in Q3 2024. 236 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

Centiva Capital reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
Centiva Capital sold 77,753 Bausch Health shares in Q4 2025, an estimated $502K.
Centiva Capital first reported a position in Bausch Health in Q4 2019 and held it in 8 quarters.
Centiva Capital's Bausch Health position peaked at $951K in Q3 2024.
236 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.